CN109364209A - A kind of cataplasm thermal sensation drug paste and preparation method thereof - Google Patents
A kind of cataplasm thermal sensation drug paste and preparation method thereof Download PDFInfo
- Publication number
- CN109364209A CN109364209A CN201811140008.2A CN201811140008A CN109364209A CN 109364209 A CN109364209 A CN 109364209A CN 201811140008 A CN201811140008 A CN 201811140008A CN 109364209 A CN109364209 A CN 109364209A
- Authority
- CN
- China
- Prior art keywords
- parts
- drug
- cataplasm
- thermal sensation
- paste
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 52
- 229940079593 drug Drugs 0.000 title claims abstract description 46
- 230000035807 sensation Effects 0.000 title claims abstract description 19
- 238000002360 preparation method Methods 0.000 title claims abstract description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 7
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 6
- 240000004307 Citrus medica Species 0.000 claims abstract description 5
- 235000015489 Emblica officinalis Nutrition 0.000 claims abstract description 5
- 244000062241 Kaempferia galanga Species 0.000 claims abstract description 5
- 235000013421 Kaempferia galanga Nutrition 0.000 claims abstract description 5
- 244000270834 Myristica fragrans Species 0.000 claims abstract description 5
- 235000009421 Myristica fragrans Nutrition 0.000 claims abstract description 5
- 241001522129 Pinellia Species 0.000 claims abstract description 5
- 244000299790 Rheum rhabarbarum Species 0.000 claims abstract description 5
- 235000009411 Rheum rhabarbarum Nutrition 0.000 claims abstract description 5
- 240000006079 Schisandra chinensis Species 0.000 claims abstract description 5
- 235000008422 Schisandra chinensis Nutrition 0.000 claims abstract description 5
- 244000277583 Terminalia catappa Species 0.000 claims abstract description 5
- 235000011517 Terminalia chebula Nutrition 0.000 claims abstract description 5
- 239000001702 nutmeg Substances 0.000 claims abstract description 5
- 241001078983 Tetradium ruticarpum Species 0.000 claims abstract description 4
- 239000008367 deionised water Substances 0.000 claims abstract description 4
- 229910021641 deionized water Inorganic materials 0.000 claims abstract description 4
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 18
- 239000000843 powder Substances 0.000 claims description 13
- 229910052613 tourmaline Inorganic materials 0.000 claims description 13
- 229940070527 tourmaline Drugs 0.000 claims description 13
- 239000011032 tourmaline Substances 0.000 claims description 13
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 9
- 238000003756 stirring Methods 0.000 claims description 9
- -1 polyethylene Polymers 0.000 claims description 8
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 7
- 239000007788 liquid Substances 0.000 claims description 7
- 239000000243 solution Substances 0.000 claims description 7
- AXTGDCSMTYGJND-UHFFFAOYSA-N 1-dodecylazepan-2-one Chemical compound CCCCCCCCCCCCN1CCCCCC1=O AXTGDCSMTYGJND-UHFFFAOYSA-N 0.000 claims description 6
- VLDFMKOUUQYFGF-UHFFFAOYSA-N 4-(butoxymethyl)-2-methoxyphenol Chemical compound CCCCOCC1=CC=C(O)C(OC)=C1 VLDFMKOUUQYFGF-UHFFFAOYSA-N 0.000 claims description 6
- 239000004698 Polyethylene Substances 0.000 claims description 6
- 239000002202 Polyethylene glycol Substances 0.000 claims description 6
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 claims description 6
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 6
- GUJOJGAPFQRJSV-UHFFFAOYSA-N dialuminum;dioxosilane;oxygen(2-);hydrate Chemical compound O.[O-2].[O-2].[O-2].[Al+3].[Al+3].O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O GUJOJGAPFQRJSV-UHFFFAOYSA-N 0.000 claims description 6
- 238000004945 emulsification Methods 0.000 claims description 6
- 229940044949 eucalyptus oil Drugs 0.000 claims description 6
- 239000010642 eucalyptus oil Substances 0.000 claims description 6
- 229910052901 montmorillonite Inorganic materials 0.000 claims description 6
- 239000004745 nonwoven fabric Substances 0.000 claims description 6
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 claims description 6
- 229920000573 polyethylene Polymers 0.000 claims description 6
- 229920001223 polyethylene glycol Polymers 0.000 claims description 6
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 claims description 6
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 claims description 6
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 claims description 6
- 229940078465 vanillyl butyl ether Drugs 0.000 claims description 6
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 claims description 5
- 229910021485 fumed silica Inorganic materials 0.000 claims description 5
- 230000001681 protective effect Effects 0.000 claims description 5
- 239000000661 sodium alginate Substances 0.000 claims description 5
- 235000010413 sodium alginate Nutrition 0.000 claims description 5
- 229940005550 sodium alginate Drugs 0.000 claims description 5
- 238000000034 method Methods 0.000 claims description 4
- 239000007864 aqueous solution Substances 0.000 claims description 3
- 230000004888 barrier function Effects 0.000 claims description 3
- 235000009508 confectionery Nutrition 0.000 claims description 3
- 239000012530 fluid Substances 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 239000003921 oil Substances 0.000 claims description 3
- 238000004659 sterilization and disinfection Methods 0.000 claims description 3
- 244000025254 Cannabis sativa Species 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 230000001112 coagulating effect Effects 0.000 claims 1
- 239000000945 filler Substances 0.000 claims 1
- 239000003906 humectant Substances 0.000 claims 1
- 239000006210 lotion Substances 0.000 claims 1
- 230000000149 penetrating effect Effects 0.000 claims 1
- 239000000377 silicon dioxide Substances 0.000 claims 1
- STZCRXQWRGQSJD-UHFFFAOYSA-N sodium;4-[[4-(dimethylamino)phenyl]diazenyl]benzenesulfonic acid Chemical compound [Na+].C1=CC(N(C)C)=CC=C1N=NC1=CC=C(S(O)(=O)=O)C=C1 STZCRXQWRGQSJD-UHFFFAOYSA-N 0.000 claims 1
- 206010012735 Diarrhoea Diseases 0.000 abstract description 31
- 230000008673 vomiting Effects 0.000 abstract description 12
- 210000000952 spleen Anatomy 0.000 abstract description 11
- 206010037660 Pyrexia Diseases 0.000 abstract description 6
- 210000004916 vomit Anatomy 0.000 abstract description 5
- 208000004998 Abdominal Pain Diseases 0.000 abstract description 4
- 206010000060 Abdominal distension Diseases 0.000 abstract description 4
- 208000004232 Enteritis Diseases 0.000 abstract description 4
- 210000003608 fece Anatomy 0.000 abstract description 4
- 208000024891 symptom Diseases 0.000 abstract description 4
- 208000019637 Infantile Diarrhea Diseases 0.000 abstract description 2
- 239000002689 soil Substances 0.000 abstract description 2
- 230000000694 effects Effects 0.000 description 10
- 206010047700 Vomiting Diseases 0.000 description 9
- 208000001848 dysentery Diseases 0.000 description 9
- 230000006870 function Effects 0.000 description 9
- 235000019615 sensations Nutrition 0.000 description 9
- 208000002193 Pain Diseases 0.000 description 8
- 230000007812 deficiency Effects 0.000 description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 206010011224 Cough Diseases 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 6
- 239000008280 blood Substances 0.000 description 6
- 201000010099 disease Diseases 0.000 description 6
- 201000006549 dyspepsia Diseases 0.000 description 6
- 230000006872 improvement Effects 0.000 description 6
- 206010062717 Increased upper airway secretion Diseases 0.000 description 5
- 208000019790 abdominal distention Diseases 0.000 description 5
- 235000013305 food Nutrition 0.000 description 5
- 208000026435 phlegm Diseases 0.000 description 5
- 210000002784 stomach Anatomy 0.000 description 5
- 206010023126 Jaundice Diseases 0.000 description 4
- 230000036528 appetite Effects 0.000 description 4
- 235000019789 appetite Nutrition 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 238000000386 microscopy Methods 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 206010010774 Constipation Diseases 0.000 description 3
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 3
- 241000702670 Rotavirus Species 0.000 description 3
- 230000001142 anti-diarrhea Effects 0.000 description 3
- 210000000436 anus Anatomy 0.000 description 3
- 230000002612 cardiopulmonary effect Effects 0.000 description 3
- 230000013872 defecation Effects 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 208000002173 dizziness Diseases 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 208000035861 hematochezia Diseases 0.000 description 3
- 210000000936 intestine Anatomy 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 201000010727 rectal prolapse Diseases 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 231100000331 toxic Toxicity 0.000 description 3
- 230000002588 toxic effect Effects 0.000 description 3
- 206010063409 Acarodermatitis Diseases 0.000 description 2
- 206010007247 Carbuncle Diseases 0.000 description 2
- 206010067715 Gastrointestinal sounds abnormal Diseases 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 208000015817 Infant Nutrition disease Diseases 0.000 description 2
- 206010024229 Leprosy Diseases 0.000 description 2
- 239000004909 Moisturizer Substances 0.000 description 2
- 206010028735 Nasal congestion Diseases 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- 206010067171 Regurgitation Diseases 0.000 description 2
- 241000447727 Scabies Species 0.000 description 2
- 206010053615 Thermal burn Diseases 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 230000004596 appetite loss Effects 0.000 description 2
- 238000002555 auscultation Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 238000001802 infusion Methods 0.000 description 2
- 239000011256 inorganic filler Substances 0.000 description 2
- 229910003475 inorganic filler Inorganic materials 0.000 description 2
- 208000019017 loss of appetite Diseases 0.000 description 2
- 235000021266 loss of appetite Nutrition 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000002366 mineral element Substances 0.000 description 2
- 230000001333 moisturizer Effects 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 239000003961 penetration enhancing agent Substances 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 208000005687 scabies Diseases 0.000 description 2
- 230000004936 stimulating effect Effects 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- YTHKMAIVPFVDNU-GPTWTFMPSA-N 4-[[(1r,2r,4ar,5r,8as)-2-(3-carboxypropanoyloxy)-1,4a-dimethyl-6-methylidene-5-[(e)-2-(5-oxo-2h-furan-4-yl)ethenyl]-3,4,5,7,8,8a-hexahydro-2h-naphthalen-1-yl]methoxy]-4-oxobutanoic acid Chemical compound C(/[C@@H]1C(=C)CC[C@H]2[C@@]1(C)CC[C@H]([C@]2(COC(=O)CCC(O)=O)C)OC(=O)CCC(O)=O)=C\C1=CCOC1=O YTHKMAIVPFVDNU-GPTWTFMPSA-N 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 244000241235 Citrullus lanatus Species 0.000 description 1
- 235000012828 Citrullus lanatus var citroides Nutrition 0.000 description 1
- 206010012742 Diarrhoea infectious Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 206010013952 Dysphonia Diseases 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 206010014418 Electrolyte imbalance Diseases 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 208000012895 Gastric disease Diseases 0.000 description 1
- 206010018045 Gastroptosis Diseases 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010019909 Hernia Diseases 0.000 description 1
- 208000031361 Hiccup Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 235000006041 Prunus persica f compressa Nutrition 0.000 description 1
- 240000006522 Prunus persica f. compressa Species 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 208000008350 Pruritus Vulvae Diseases 0.000 description 1
- 208000004680 Rectal Fistula Diseases 0.000 description 1
- 206010039101 Rhinorrhoea Diseases 0.000 description 1
- IWUCXVSUMQZMFG-AFCXAGJDSA-N Ribavirin Chemical compound N1=C(C(=O)N)N=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 IWUCXVSUMQZMFG-AFCXAGJDSA-N 0.000 description 1
- 241000593989 Scardinius erythrophthalmus Species 0.000 description 1
- 206010043189 Telangiectasia Diseases 0.000 description 1
- 208000007074 Trichomonas Vaginitis Diseases 0.000 description 1
- 208000025206 Trichomonas vaginitis urogenital infection Diseases 0.000 description 1
- 206010056530 Vulvovaginal pruritus Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 208000020560 abdominal swelling Diseases 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 206010002156 anal fistula Diseases 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 229940125714 antidiarrheal agent Drugs 0.000 description 1
- 239000003793 antidiarrheal agent Substances 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 239000003212 astringent agent Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000002146 bilateral effect Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000003833 cell viability Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 235000020965 cold beverage Nutrition 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 206010016766 flatulence Diseases 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 210000002683 foot Anatomy 0.000 description 1
- 208000003512 furunculosis Diseases 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 208000027692 gas pain Diseases 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 230000000004 hemodynamic effect Effects 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 208000027498 hoarse voice Diseases 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 239000002917 insecticide Substances 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 244000000053 intestinal parasite Species 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 201000005630 leukorrhea Diseases 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 208000010753 nasal discharge Diseases 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 210000003800 pharynx Anatomy 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 210000000697 sensory organ Anatomy 0.000 description 1
- 229910021647 smectite Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 208000009056 telangiectasis Diseases 0.000 description 1
- 201000004647 tinea pedis Diseases 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 206010046901 vaginal discharge Diseases 0.000 description 1
- 229940100050 virazole Drugs 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 210000003905 vulva Anatomy 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 229940126673 western medicines Drugs 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/285—Aucklandia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/489—Sophora, e.g. necklacepod or mamani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/57—Magnoliaceae (Magnolia family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/57—Magnoliaceae (Magnolia family)
- A61K36/575—Magnolia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/67—Piperaceae (Pepper family), e.g. Jamaican pepper or kava
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/708—Rheum (rhubarb)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/754—Evodia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/79—Schisandraceae (Schisandra family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
- A61K36/8888—Pinellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9062—Alpinia, e.g. red ginger or galangal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/44—Applying ionised fluids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0613—Apparatus adapted for a specific treatment
- A61N5/0625—Warming the body, e.g. hyperthermia treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
- A61N2005/0659—Radiation therapy using light characterised by the wavelength of light used infrared
- A61N2005/066—Radiation therapy using light characterised by the wavelength of light used infrared far infrared
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medical Informatics (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Microbiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Radiology & Medical Imaging (AREA)
- Nutrition Science (AREA)
- Dermatology (AREA)
- Inorganic Chemistry (AREA)
- Pathology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a kind of cataplasm thermal sensation drug pastes, the drug paste includes primary backing, and paste layer is arranged on primary backing, drug ingedient is arranged on paste layer, it in mass ratio include consisting of: 1 ~ 3 part of raw rhubarb, 6 ~ 10 parts of Cortex Magnoliae Officinalis, 6 ~ 10 parts of fructus piperis longi, 5 ~ 8 parts of evodia rutaecarpa, 3 ~ 6 parts of radix aucklandiae, 3 ~ 5 parts of Schisandra sphnanthera, 3 ~ 6 parts of Radix picrorrhizae, 6 ~ 10 parts of the tuber of pinellia, 3 ~ 6 parts of the dried immature fruit of citron orange, 6 ~ 10 parts of galanga, 6 ~ 10 parts of myrobalan, 3 ~ 6 parts of nutmeg, 1 ~ 3 part of kuh-seng, 100 ~ 150 parts of deionized water, unique formula of the invention, preparation method is reasonable；Suitable for eliminating dampness to stop diarrhea and fortune spleen, for infantile diarrhea caused by wet tired spleen soil, symptoms include: diarrhea, loose watery stool or water sample, abdominal distension, abdominal pain, receive it is poor, vomit or see that greasy fever, pale tongue with white fur and rotaviral enteritis and noninfectious diarrhea are shown in above-mentioned patient.
Description
Technical field:
The present invention relates to field of medicaments, in particular to a kind of cataplasm thermal sensation drug paste and preparation method thereof.
Background technique:
Baby diarrhea is China's infant's common disease, seriously affects the health and growth and development of children, particularly infant, in the past
It is mainly treated with western medicine antibiotics, but Western medicine toxic side effect is big, and current Traditional Chinese medicine antidiarrheal is only for weakness of the spleen and the stomach caused
Digestive tract function disorder is treated: extensively plain antidiarrhea oral liquid just makes up the deficiency of front antidiarrheal agent to children, has no toxic side effect,
The effects of capable of inhibiting and kill Escherichia coli and rotavirus, having spleen benefiting and stimulating the appetite concurrently, bring down a fever, help digestion and improve immunity of organisms.
Meanwhile this product has adjustment effect to dehydration, electrolyte imbalance caused by diarrhea rich in body trace elements such as potassium, sodium, magnesium, zinc.
Raw rhubarb purges heat logical intestines, dispelling stasis of blood and stimulating the menstrual flow, removing pattogenic heat from the blood and toxic material from the body.For blood stasis closed, traumatic injury, jaundice with damp-heat pathogen, blood-head
Hematemesis, real heat constipation, stagnate abdominal pain, and abdominalgia with intestinal abscess, dysentery is not well, hot eyes, pharynx swelling, and carbuncle swells furunculosis controls scald outside;On disappear
Change gastrointestinal hemorrhage.
Cortex Magnoliae Officinalis is the major functions: stagnation of QI due to dyspepsia；Abdominal distention constipation；Damp retention in middle-jiao, abdominal swelling and diarrhea；Phlegm stops up the circulation of vital energy in the wrong direction；Chest full of cough.
Fructus piperis longi is the major functions: for coldness and pain in the epigastrium, vomiting, diarrhea, vomit acid regurgitation, increased borborygmus and diarrhea, cold dysentery.
Evodia rutaecarpa: major function eliminating cold to stop pain, stopping nausea and vomiting by lowering the adverse flow of QI, supporing yang antidiarrheal.For jueyin headache, cold hernia stomachache, cold-dampness
Tinea pedis, dysmenorrhea, abdominal distention vomit acid regurgitation, and Diarrhoea controls aphtha outside；Hypertension.
Radix aucklandiae, [curing mainly]: born of the same parents coerce turgor foot；Abdominal distention；Vomiting and having loose bowel；Weight after dysentery.
Schisandra sphnanthera: fruit controls indigestion, enteritis, diarrhea, vomits hiccup, gas pain, faintness dizziness,
Radix picrorrhizae is the major functions: deficiency of Yin hectic fever due to yin；Hectic fever night sweat；Infant malnutrition；Damp-heat dysentery；Jaundice；It spits blood；Bleeding from five sense organs or subcutaneous tissue；Red eye, swell pain；Carbuncle
Swollen sore；Hemorrhoid pyogenic infections
The tuber of pinellia [major function] is eliminating dampness and eliminating phlegm, stopping nausea and vomiting by lowering the adverse flow of QI, dissolving lump and resolving mass.Wet phlegm and cold drink is controlled, is vomitted, gastric disorder causing nausea, cough and phlegm, chest
Diaphragm turgor, phlegm and headache, dizziness and sleepless.Outer subduing inflammation.
Dried immature fruit of citron orange effect internal stagnation；Feeling of fullness distending pain；Constipation；Weight after rush down dysentery；Accumulation of pathogens in chest；Gastroptosis；Rectal prolapse.
The effect of myrobalan has relieving diarrhea with astringents, astringes the lung to stop cough, fall fire relieving sore-throat.It is usually used in protracted dysentery and diarrhea, hematochezia rectal prolapse, the deficiency syndrome of the lung
It breathes with cough, coughs long more than, pharyngalgia hoarse voice.
Galanga can pungent scattered temperature it is logical, eliminating cold to stop pain, for the common medicine for the treatment of stomach cold coldness and pain in the epigastrium, gastrofrigid vomiting: meridian distribution of property and flavor:
Pungent, hot, returns spleen, stomach meridian.Major function: eliminating cold to stop pain, warming middle energizer to arrest vomiting.
The puckery intestines of nutmeg major function middle benefit gas;Promoting the circulation of qi helps digestion.Main void is rushed down;Cold dysentery;Abdominal distention;Deficiency of food vomiting;It eats not place
Disappear.
[the effect of kuh-seng and effect]:
Heat-clearing and damp-drying drug；Wind dispelling insecticide.Main damp-heat dysentery；Hematochezia；Jaundice；Difficult urination；Oedema；Leukorrhagia；Pruritus vulvae；Scabies；
Leprosy；Pruitus；Wet poison sore.Control toxic-heat and blood stasis, discharging fresh blood stool, jaundice, leukorrhea with reddish discharge, infantile pneumonia, infantile malnutrition due to digestive disturbances or intestinalparasites is acute flat
Peach body is scorching, and anal fistula, rectal prolapse, pruitus, scabies leprosy malignant sore, the erosion of vulva is wet to itch, scrofula, scald.Trichomonas vaginitis is controlled outside.
Tourmaline health care effect
1, releasing negative oxygen ion: the negative oxygen ion that tourmaline is discharged can quickly improve air quality, promote the new old generation of cell
It thanks, enhances cell viability, neutralize free radical, purification blood, pacify nerve, recover from fatigue, improve a poor appetite.In addition, anion
Also being identified has the function of killing germ, purification air；
2, far infrared: the far infrared that tourmaline is discharged is discharged, human body cell and body fluid molecule can be made to generate resonance effects,
Telangiectasis, Hemodynamic environment is enabled to accelerate, to improve the oxygen content of body, the macromoleculars living matter such as activation of protein increases
Add the reparation and power of regeneration of tissue, improves body immunity；
3, discharge the micro-current of 0.06mA: tourmaline flows the 0.06mA substantially identical with human biological electricity because of its surface always
Micro-current can supplement and adjust at any time the bioelectricity of human body, allow pathology current potential to restore normal, to play the work of sports health care
With；
4, natural energy field activating cell: tourmaline crystal is known as natural solar battery.It can absorb, store the sun
Luminous energy, and be allowed to be converted to electric energy (bioelectricity) and the form of thermal energy (far infrared) releases, form eternal Tourmaline
Energy field supplies human body cell continuously with energy；
5, effectively block harmful radiation: tourmaline product can effectively block the harmful radiations such as unwanted electromagnetic wave, water vein waves to human body
Infringement；
6, it is rich in several kinds of mineral elements: containing several kinds of mineral elements (Mg, Fe, B, Si, Ca etc.), effectively adjusting human nutrition element
Balance.
Summary of the invention:
Technical solution:
To solve the above-mentioned problems, the present invention provides with treating both manifestation and root cause of disease, it can inhibit, kill germ, and can keep fit and healthy,
The growth and development of infant is not influenced, rich in various trace elements, there is the treatment baby diarrhea of synergistic effect with " oral rehydration "
And the cataplasm thermal sensation drug paste and preparation method of child infectious diarrhea.
The technical solution that the present invention takes to achieve the above object are as follows:
A kind of cataplasm thermal sensation drug paste, the drug paste include primary backing, and paste layer, the paste layer are arranged on the primary backing
Upper setting drug ingedient includes consisting of in mass ratio: 1 ~ 3 part of raw rhubarb, 6 ~ 10 parts of Cortex Magnoliae Officinalis, and 6 ~ 10 parts of fructus piperis longi, Wu Zhu
5 ~ 8 parts of cornel, 3 ~ 6 parts of radix aucklandiae, 3 ~ 5 parts of Schisandra sphnanthera, 3 ~ 6 parts of Radix picrorrhizae, 6 ~ 10 parts of the tuber of pinellia, 3 ~ 6 parts of the dried immature fruit of citron orange, galanga 6 ~
10 parts, 6 ~ 10 parts of myrobalan, 3 ~ 6 parts of nutmeg, 1 ~ 3 part of kuh-seng, 100 ~ 150 parts of deionized water.
As a further improvement, the drug ingedient further includes solidifying paste, the solidifying paste include in mass ratio with
Lower composition: 2 ~ 5 parts of citric acid, 3 ~ 10 parts of sodium alginate, 3 ~ 10 parts of Sodium Polyacrylate, 2 ~ 5 parts of sodium carboxymethylcellulose；
As a further improvement, the drug ingedient further includes moisturizer, it in mass ratio include consisting of: glycerol 5 ~ 10
Part, 1 ~ 3 part of polyethylene glycol；
As a further improvement, the drug ingedient further includes inorganic filler, it in mass ratio include consisting of: nanometer day
Right 5 ~ 10 parts of tourmaline powder, 5 ~ 10 parts of nano montmorillonite powder, 20 ~ 30 parts of fumed silica；
As a further improvement, the drug ingedient further includes transdermal penetration enhancer, in mass ratio include consisting of: azone 2 ~
5 parts, 2 ~ 5 parts of eucalyptus oil；
As a further improvement, the drug ingedient further includes exothermic mixture, it in mass ratio include consisting of: vanillyl butyl ether
1 ~ 3 part；
As a further improvement, protective film is arranged on the paste layer, the protective film is polyethylene film, the primary backing
For non-woven fabrics；
A kind of production method of cataplasm thermal sensation drug paste, method includes the following steps:
1) sodium alginate, Sodium Polyacrylate are dissolved under 60 DEG C of aqueous solutions, are added sodium carboxymethylcellulose, 60 DEG C of constant temperature with
100 ~ 200r/min stirs 30 ~ 40min；
2), fumed silica and drug solution described in claim 1 are mixed, be added citric acid, with temperature 50 ~
60 degree, 2000 ~ 3000r/min high-speed stirred, 40 ~ 60min；
3), the liquid of above two step is mixed, tourmaline powder, montmorillonite powder is added, stirs 20 ~ 30 minutes, is then added sweet
Oil, polyethylene glycol, azone, eucalyptus oil, vanillyl butyl ether were kept for 50 ~ 60 degree, with 300 ~ 500r/min stirring 30 ~ 50 minutes；
4), mixing liquid is put into ultrasonic emulsification instrument, is kept for 50 ~ 60 degree of temperature, with 40 ~ 50KHz, ultrasonic emulsification 30 ~
50 minutes, 2 ~ 5 hours then were stood under ultraviolet disinfection lamp；
5), the medical fluid that will have been emulsified is laid on non-woven fabrics, and 1 ~ 1.5mm of thickness, 50 DEG C are dried 50 ~ 70 minutes, and polyethylene is then covered
Film antiadhesion barrier, is cut into 5 × 8 square centimeters of cataplasm, and sealed package gets product cataplasm.
Beneficial effects of the present invention: unique formula of the invention, preparation method are reasonable；Belong to field of medicaments, be suitable for eliminating dampness to stop diarrhea,
With middle fortune spleen.For infantile diarrhea caused by wet tired spleen soil.Symptoms include: diarrhea, loose watery stool or water sample, abdominal distension, abdominal pain, receive it is poor,
Vomiting is shown in that greasy fever, pale tongue with white fur and rotaviral enteritis and noninfectious diarrhea are shown in above-mentioned patient.
Specific embodiment:
A kind of cataplasm thermal sensation drug paste, the drug paste include primary backing, and paste layer, the paste layer are arranged on the primary backing
Upper setting drug ingedient includes consisting of in mass ratio: 2 parts of raw rhubarb, 8 parts of Cortex Magnoliae Officinalis, and 8 parts of fructus piperis longi, 7 parts of evodia rutaecarpa, wood
It is 5 parts fragrant, 4 parts of Schisandra sphnanthera, 4 parts of Radix picrorrhizae, 8 parts of the tuber of pinellia, 5 parts of the dried immature fruit of citron orange, 7 parts of galanga, 7 parts of myrobalan, 7 parts of nutmeg, kuh-seng
7 parts, 100 parts of deionized water；
The drug ingedient further includes solidifying paste, and the solidifying paste includes consisting of in mass ratio: 4 parts of citric acid, sea
5 parts of mosanom, 6 parts of Sodium Polyacrylate, 3 parts of sodium carboxymethylcellulose；
The drug ingedient further includes moisturizer, in mass ratio includes consisting of: 7 parts of glycerol, 2 parts of polyethylene glycol；
The drug ingedient further includes inorganic filler, in mass ratio includes consisting of: 8 parts of nanometer crude tourmaline powder,
8 parts of nano montmorillonite powder, 25 parts of fumed silica；
The drug ingedient further includes transdermal penetration enhancer, in mass ratio includes consisting of: 3 parts of azone, 3 parts of eucalyptus oil；
The drug ingedient further includes exothermic mixture, in mass ratio includes consisting of: 2 parts of vanillyl butyl ether；
Protective film is set on the paste layer, and the protective film is polyethylene film, and the primary backing is non-woven fabrics；
A kind of production method of cataplasm thermal sensation drug paste, method includes the following steps:
1) sodium alginate, Sodium Polyacrylate are dissolved under 60 DEG C of aqueous solutions, are added sodium carboxymethylcellulose, 60 DEG C of constant temperature with
100 ~ 200r/min stirs 30 ~ 40min；
2), fumed silica and drug solution described in claim 1 are mixed, be added citric acid, with temperature 50 ~
60 degree, 2000 ~ 3000r/min high-speed stirred, 40 ~ 60min；
3), the liquid of above two step is mixed, tourmaline powder, montmorillonite powder is added, stirs 20 ~ 30 minutes, is then added sweet
Oil, polyethylene glycol, azone, eucalyptus oil, vanillyl butyl ether were kept for 50 ~ 60 degree, with 300 ~ 500r/min stirring 30 ~ 50 minutes；
4), mixing liquid is put into ultrasonic emulsification instrument, is kept for 50 ~ 60 degree of temperature, with 40 ~ 50KHz, ultrasonic emulsification 30 ~
50 minutes, 2 ~ 5 hours then were stood under ultraviolet disinfection lamp；
5), the medical fluid that will have been emulsified is laid on non-woven fabrics, and 1 ~ 1.5mm of thickness, 50 DEG C are dried 50 ~ 70 minutes, and polyethylene is then covered
Film antiadhesion barrier, is cut into 5 × 8 square centimeters of cataplasm, and sealed package gets product cataplasm.
Typical case:
Example one: Lee's ××, female, 2 years old, because diarrhea is gone to a doctor more than January, infant ferritic was weakness of the spleen and the stomach, every improper because catching a cold or feeding
And induce diarrhea.It can be relieved every time through 5 days or more infusion treatment rears, this diarrhea caused after cold, fever before January,
In certain higher level hospital through enzyme-linked immunosorbent assay, the rotavirus positive is found, rotavirus enteritis is diagnosed as.In successive intravenous infusion
Potassium dehydroandrographolide succinate needle, virazole needle etc., the Chinese and Western medicines such as intramuscular injection interferon and oral dioctahedral smectite now still rush down loose stools, 5-7 times daily.Existing disease
Shape: face Huang shape is thin, and tired, deficiency of food is indigestion and loss of appetite, and more than diarrhea after food, loose watery stool, indigestion is 5-7 times daily.Physical examination:
36.8 DEG C of armpit temperature, anus color is light, not red pneumonedema, and gauffer tide is viscous, and pale tongue with white fur is greasy, soft and moderate pulse.Auscultation: cardiopulmonary are without exception, borborygmus
Sound is active, microscopy of defecating: fat globule ++, the visual field leucocyte 1-2/, red blood cell (-).Diagnosis: cold-dampness type diarrhea, syndrome of spleen deficiency are obvious.
Cataplasm thermal sensation drug paste outer patch umbilical region of the present invention is applied alone.Very night times of defecation is reduced.It checks within second day, times of defecation obviously subtracts
Few, stool gradually shapes, and infant appetite is enhanced, and 3 patches are used in conjunction and went to a doctor later, and stool forming, chromaticness is normal, and 1-2 times/day,
Microscopy of defecating is normal, all disease recoveries from illness.Follow-up after 3 months, infant diarrhea do not recur again.
Example two: Zhao's ××, male, 9 months, because infant diarrhea is gone to a doctor over 2 days with nasal mucus clear nasal discharge.Existing symptom: paroxysm is cry and screamed, intestines
It is loose stool after ring, thin, 8-9 times daily, the light folder foam of color of defecating, indigestion and loss of appetite, deficiency of food, nasal congestion, cough.Physical examination: armpit temperature
36.9 DEG C, anus color is light, and gauffer tide is viscous, and abdomen is soft, pale tongue, and tongue fur is thin white.Auscultation: cardiopulmonary are without exception, bowel sounds active, stool routine examination
(-).Diagnosis: wind-cold type diarrhea.It is applied alone cataplasm thermal sensation drug paste of the present invention to be applied with ZHONGWAN acupoint, very night number is reduced, and second day multiple
It looks into, has lined up shape stool once, nasal congestion mitigates, and with after 1 patch, all diseases are fully recovered.Follow-up after half a month, infant diarrhea is without multiple
Hair.
Example three: left ××, male, 5 years old, infant ferritic was weakness of the spleen and the stomach, and last night is modern because eating watermelon again after excess of being satiated with food in feast
Morning vomits 2 times, diarrhea 3 times.Loose watery stool accompanies indigestion swill.Existing symptom: sallow complexion, body is thin, and mind is tired
Power, do not feel like eating.Physical examination: 36.9 DEG C of armpit temperature, abdominal fullness and distention pain, anus color is light, and lip pale tongue, whitish tongue is greasy, and arteries and veins is thin and slides.It listens
Examine: cardiopulmonary are without exception, and gurgling sound is hyperfunction.Stool microscopy has fat drop.Diagnosis: cold diarrhea, spleen deficiency is stagnant to be proved to show.It is applied alone
The outer emplastrum of the present invention is applied with TIANSHU acupoint (bilateral), and very night times of defecation is reduced, and vomiting, abdominal pain disappears.It checks within second day, has lined up
Shape stool is primary, and appetite increases, and abdominal distension disappears.Again with after 2 patches, all diseases are fully recovered, and stool microscopy is normal.Follow-up after 2 months is suffered from
Youngster's diarrhea is without recurrence.
In addition, it should be understood that although this specification is described in terms of embodiments, but not each embodiment is only wrapped
Containing an independent technical solution, this description of the specification is merely for the sake of clarity, and those skilled in the art should
It considers the specification as a whole, the technical solutions in the various embodiments may also be suitably combined, forms those skilled in the art
The other embodiments being understood that.
Claims (8)
1. a kind of cataplasm thermal sensation drug paste, it is characterised in that: the drug paste includes primary backing, and lotion is arranged on the primary backing
Layer, drug ingedient is set on the paste layer, in mass ratio includes consisting of: 1 ~ 3 part of raw rhubarb, 6 ~ 10 parts of Cortex Magnoliae Officinalis, Bi
6 ~ 10 parts of the roots of grass, 5 ~ 8 parts of evodia rutaecarpa, 3 ~ 6 parts of radix aucklandiae, 3 ~ 5 parts of Schisandra sphnanthera, 3 ~ 6 parts of Radix picrorrhizae, 6 ~ 10 parts of the tuber of pinellia, the dried immature fruit of citron orange
3 ~ 6 parts, 6 ~ 10 parts of galanga, 6 ~ 10 parts of myrobalan, 3 ~ 6 parts of nutmeg, 1 ~ 3 part of kuh-seng, 100 ~ 150 parts of deionized water.
2. a kind of cataplasm thermal sensation drug paste according to claim 1, it is characterised in that: the drug ingedient further includes coagulating
Paste, the solidifying paste includes consisting of in mass ratio: 2 ~ 5 parts of citric acid, 3 ~ 10 parts of sodium alginate, Sodium Polyacrylate 3 ~
10 parts, 2 ~ 5 parts of sodium carboxymethylcellulose.
3. a kind of cataplasm thermal sensation drug paste according to claim 1, it is characterised in that: the drug ingedient further includes protecting
Humectant includes consisting of: 5 ~ 10 parts of glycerol, 1 ~ 3 part of polyethylene glycol in mass ratio.
4. a kind of cataplasm thermal sensation drug paste according to claim 1, it is characterised in that: the drug ingedient further includes nothing
Machine filler includes consisting of: 5 ~ 10 parts of nanometer crude tourmaline powder, 5 ~ 10 parts of nano montmorillonite powder, gas phase in mass ratio
20 ~ 30 parts of silica.
5. a kind of cataplasm thermal sensation drug paste according to claim 1, it is characterised in that: the drug ingedient further includes
Skin penetrating agent includes consisting of: 2 ~ 5 parts of azone, 2 ~ 5 parts of eucalyptus oil in mass ratio.
6. a kind of cataplasm thermal sensation drug paste according to claim 1, it is characterised in that: the drug ingedient further includes hair
Thermit powder includes consisting of: 1 ~ 3 part of vanillyl butyl ether in mass ratio.
7. a kind of cataplasm thermal sensation drug paste according to claim 1, it is characterised in that: protection is arranged on the paste layer
Film, the protective film are polyethylene film, and the primary backing is non-woven fabrics.
8. a kind of cataplasm thermal sensation drug paste and preparation method thereof, it is characterised in that: method includes the following steps:
1) sodium alginate, Sodium Polyacrylate are dissolved under 60 DEG C of aqueous solutions, are added sodium carboxymethylcellulose, 60 DEG C of constant temperature with
100 ~ 200r/min stirs 30 ~ 40min；
2), fumed silica and drug solution described in claim 1 are mixed, be added citric acid, with temperature 50 ~
60 degree, 2000 ~ 3000r/min high-speed stirred, 40 ~ 60min；
3), the liquid of above two step is mixed, tourmaline powder, montmorillonite powder is added, stirs 20 ~ 30 minutes, is then added sweet
Oil, polyethylene glycol, azone, eucalyptus oil, vanillyl butyl ether were kept for 50 ~ 60 degree, with 300 ~ 500r/min stirring 30 ~ 50 minutes；
4), mixing liquid is put into ultrasonic emulsification instrument, is kept for 50 ~ 60 degree of temperature, with 40 ~ 50KHz, ultrasonic emulsification 30 ~
50 minutes, 2 ~ 5 hours then were stood under ultraviolet disinfection lamp；
5), the medical fluid that will have been emulsified is laid on non-woven fabrics, and 1 ~ 1.5mm of thickness, 50 DEG C are dried 50 ~ 70 minutes, and polyethylene is then covered
Film antiadhesion barrier, is cut into 5 × 8 square centimeters of cataplasm, and sealed package gets product cataplasm.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201811140008.2A CN109364209A (en) | 2018-09-28 | 2018-09-28 | A kind of cataplasm thermal sensation drug paste and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201811140008.2A CN109364209A (en) | 2018-09-28 | 2018-09-28 | A kind of cataplasm thermal sensation drug paste and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN109364209A true CN109364209A (en) | 2019-02-22 |
Family
ID=65402954
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201811140008.2A Pending CN109364209A (en) | 2018-09-28 | 2018-09-28 | A kind of cataplasm thermal sensation drug paste and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN109364209A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110559276A (en) * | 2019-09-09 | 2019-12-13 | 左耀武 | intelligent system plaster for conditioning physique and preventing and treating various types of diarrhea and preparation method |
| CN111568884A (en) * | 2020-06-05 | 2020-08-25 | 安徽省昊祥药业有限公司 | Method for preparing Chinese medicinal patch for external use |
-
2018
- 2018-09-28 CN CN201811140008.2A patent/CN109364209A/en active Pending
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110559276A (en) * | 2019-09-09 | 2019-12-13 | 左耀武 | intelligent system plaster for conditioning physique and preventing and treating various types of diarrhea and preparation method |
| CN111568884A (en) * | 2020-06-05 | 2020-08-25 | 安徽省昊祥药业有限公司 | Method for preparing Chinese medicinal patch for external use |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102949734B (en) | Traditional Chinese medicine gastrointestinal auxiliary for type-B ultrasonic and preparation method thereof | |
| CN102935199A (en) | Chinese medicinal composition for treating chronic gastritis | |
| CN104352920A (en) | Digestion-helping and stomach-conditioning traditional Chinese medicinal composition | |
| CN109364209A (en) | A kind of cataplasm thermal sensation drug paste and preparation method thereof | |
| CN101607011B (en) | Traditional Chinese medicine for treating cholecystitis post-operative complacation | |
| CN103893611B (en) | A kind of medicine and preparation method who treats kidney stone | |
| CN102091279B (en) | Traditional Chinese medicine composition for treating duodenal ulcer | |
| CN104208561A (en) | Formula of traditional Chinese medicine for nursing gastric bezoars | |
| CN106937990B (en) | A kind of external application toxin expelling anti-inflammatory composition | |
| CN105168522A (en) | Medicament for treating abdominal distension and preparation method thereof | |
| CN110292626A (en) | A kind of emulsifiable paste and preparation method thereof for treating tinea pedis | |
| CN104857190A (en) | Foot bath nursing composition for promoting postpartum recovery | |
| CN104491364B (en) | A kind of pill and preparation method for treating chronic lymphocytic thyroiditis | |
| CN107233520A (en) | The Chinese medicine composition that a kind of eczema treated caused by rheumatism heat toxin stasis blocking is oozed out | |
| CN103417669B (en) | Drug for treatment of abdominal pain and diarrhea | |
| CN106729328A (en) | A kind of Chinese medicine composition for the treatment of cancer and its application | |
| CN107951931A (en) | A kind of smokeless moxibustion pharmaceutical composition and its application method | |
| CN106943573A (en) | It is a kind of to treat Chinese medicine of stomach trouble and preparation method thereof | |
| CN109106832A (en) | A kind of Chinese medicine lotion for external use for treating scrofula ulceration | |
| CN107029177A (en) | Pollen Typhae decoction | |
| CN104984305B (en) | A kind of Chinese medicine composition for treating chronic cholecystitis | |
| CN106266704A (en) | The Chinese medicine composition for the treatment of gastroenteritis and preparation method | |
| CN103920122B (en) | A kind of Chinese medicine preparation for treating gastroenteritis and preparation method | |
| CN104398864B (en) | A kind of Chinese medicine composition for the treatment of constipation | |
| CN105661279A (en) | Nutrient health-care porridge based on Chinese yam |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20190222 |